Maaike Meurs1, Annelieke M Roest, Bruce H R Wolffenbuttel, Ronald P Stolk, Peter de Jonge, Judith G M Rosmalen. 1. From the Departments of Psychiatry (Meurs, Roest, de Jonge, Rosmalen), Endocrinology and Metabolic Diseases (Wolffenbuttel), and Epidemiology (Stolk), Interdisciplinary Center Psychopathology and Emotion Regulation (ICPE), University of Groningen/University Medical Center Groningen, Groningen, the Netherlands.
Abstract
OBJECTIVE: To compare the odds of depressive and anxiety disorders for participants with diagnosed diabetes, participants with diabetes but unaware of this, and participants without diabetes. Such knowledge might improve etiological insight into psychopathology in diabetes. METHODS: Data of 90,686 participants (mean age = 45 years; 59% female) from the LifeLines cohort was used. Depressive and anxiety disorders were assessed by the Mini-International Neuropsychiatric Interview. The odds of depression and anxiety were assessed for three groups: a) diagnosed diabetes, diabetes medication use and/or self-reported "diabetes"; b) undiagnosed diabetes, fasting blood glucose ≥7.0 mmol/l, but no diabetes medication use and self-reported "no diabetes"; and c) no diabetes, fasting blood glucose <7.0 mmol/l and self-reported "no diabetes." Logistic regression was performed to compare the odds of depression and anxiety in these groups, adjusting for age, sex, diabetes-related diseases, comorbid depressive or anxiety disorders, and glycosylated hemoglobin. RESULTS: A total of 3002 (3.3%) participants were diagnosed as having depression and 9018 (9.9%) as having anxiety; 1781 (2.0%) had diagnosed and 786 (0.9%) had undiagnosed diabetes. Both diagnosed (odds ratio [OR] = 1.4:1.1-1.8, p = .006) and undiagnosed (OR = 1.8:1.3-2.6, p = .001) diabetes were independently associated with depression. The odds of depression did not differ between diagnosed and undiagnosed diabetes (OR = 0.7, p = .17). Diagnosed diabetes was independently associated with anxiety (OR = 1.4:1.2-1.7, p < .001), but undiagnosed diabetes was not (OR = 0.8:0.6-1.1, p = .20). The odds of anxiety were significantly higher in diagnosed compared with undiagnosed diabetes (1.68:1.23-2.31, p = .001). CONCLUSIONS: Depression was more prevalent in participants with diagnosed and undiagnosed diabetes, whereas anxiety was more prevalent only in participants who were aware of their diabetes. Longitudinal research is needed to assess the causal pathways of these associations.
OBJECTIVE: To compare the odds of depressive and anxiety disorders for participants with diagnosed diabetes, participants with diabetes but unaware of this, and participants without diabetes. Such knowledge might improve etiological insight into psychopathology in diabetes. METHODS: Data of 90,686 participants (mean age = 45 years; 59% female) from the LifeLines cohort was used. Depressive and anxiety disorders were assessed by the Mini-International Neuropsychiatric Interview. The odds of depression and anxiety were assessed for three groups: a) diagnosed diabetes, diabetes medication use and/or self-reported "diabetes"; b) undiagnosed diabetes, fasting blood glucose ≥7.0 mmol/l, but no diabetes medication use and self-reported "no diabetes"; and c) no diabetes, fasting blood glucose <7.0 mmol/l and self-reported "no diabetes." Logistic regression was performed to compare the odds of depression and anxiety in these groups, adjusting for age, sex, diabetes-related diseases, comorbid depressive or anxiety disorders, and glycosylated hemoglobin. RESULTS: A total of 3002 (3.3%) participants were diagnosed as having depression and 9018 (9.9%) as having anxiety; 1781 (2.0%) had diagnosed and 786 (0.9%) had undiagnosed diabetes. Both diagnosed (odds ratio [OR] = 1.4:1.1-1.8, p = .006) and undiagnosed (OR = 1.8:1.3-2.6, p = .001) diabetes were independently associated with depression. The odds of depression did not differ between diagnosed and undiagnosed diabetes (OR = 0.7, p = .17). Diagnosed diabetes was independently associated with anxiety (OR = 1.4:1.2-1.7, p < .001), but undiagnosed diabetes was not (OR = 0.8:0.6-1.1, p = .20). The odds of anxiety were significantly higher in diagnosed compared with undiagnosed diabetes (1.68:1.23-2.31, p = .001). CONCLUSIONS:Depression was more prevalent in participants with diagnosed and undiagnosed diabetes, whereas anxiety was more prevalent only in participants who were aware of their diabetes. Longitudinal research is needed to assess the causal pathways of these associations.
Authors: Kadri Haljas; Azmeraw T Amare; Behrooz Z Alizadeh; Yi-Hsiang Hsu; Thomas Mosley; Anne Newman; Joanne Murabito; Henning Tiemeier; Toshiko Tanaka; Cornelia van Duijn; Jingzhong Ding; David J Llewellyn; David A Bennett; Antonio Terracciano; Lenore Launer; Karl-Heinz Ladwig; Marylin C Cornelis; Alexander Teumer; Hans Grabe; Sharon L R Kardia; Erin B Ware; Jennifer A Smith; Harold Snieder; Johan G Eriksson; Leif Groop; Katri Räikkönen; Jari Lahti Journal: Psychosom Med Date: 2018-04 Impact factor: 4.312
Authors: Zhao Li; Xiaofan Guo; Hongkun Jiang; Guozhe Sun; Yingxian Sun; Maria Roselle Abraham Journal: Int J Environ Res Public Health Date: 2016-11-14 Impact factor: 3.390
Authors: Anna Chapman; Shuo Liu; Stephanie Merkouris; Joanne C Enticott; Hui Yang; Colette J Browning; Shane A Thomas Journal: Front Public Health Date: 2015-11-16